Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells
Sorafenib (Sfb) is a multikinase inhibitor regularly used for the management of patients with advanced hepatocellular carcinoma (HCC) that has been shown to increase very modestly life expectancy. We have shown that Sfb inhibits protein synthesis at the level of initiation in cancer cells. However,...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Universidad de Sevilla (US) |
| Repositorio: | idUS. Depósito de Investigación de la Universidad de Sevilla |
| OAI Identifier: | oai:idus.us.es:11441/172458 |
| Acceso en línea: | https://hdl.handle.net/11441/172458 https://doi.org/10.1080/15476286.2025.2483484 |
| Access Level: | acceso abierto |
| Palabra clave: | Hepatocellular carcinoma m6A methylation Polysome profiling Sorafenib Translation |
| id |
ES_e45fd8d3f2dc373f8e30d509be75fa2f |
|---|---|
| oai_identifier_str |
oai:idus.us.es:11441/172458 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cellsContreras Bernal, LauraRodríguez Gil, AlfonsoMuntané Relat, JordiCruz Díaz, Jesús de laHepatocellular carcinomam6A methylationPolysome profilingSorafenibTranslationSorafenib (Sfb) is a multikinase inhibitor regularly used for the management of patients with advanced hepatocellular carcinoma (HCC) that has been shown to increase very modestly life expectancy. We have shown that Sfb inhibits protein synthesis at the level of initiation in cancer cells. However, the global snapshot of mRNA translation following Sorafenib-treatment has not been explored so far. In this study, we performed a genome-wide polysome profiling analysis in Sfb-treated HCC cells and demonstrated that, despite global translation repression, a set of different genes remain efficiently translated or are even translationally induced. We reveal that, in response to Sfb inhibition, translation is tuned, which strongly correlates with the presence of established mRNA cis-acting elements and the corresponding protein factors that recognize them, including DAP5 and ARE-binding proteins. At the level of biological processes, Sfb leads to the translational down-regulation of key cellular activities, such as those related to the mitochondrial metabolism and the collagen synthesis, and the translational up-regulation of pathways associated with the adaptation and survival of cells in response to the Sfb-induced stress. Our findings indicate that Sfb induces an adaptive reprogramming of translation and provides valuable information that can facilitate the analysis of other drugs for the development of novel combined treatment strategies based on Sfb therapy.Taylor and Francis Ltd.Fisiología Médica y BiofísicaGenéticaEuropean Cooperation in Science and TechnologyMinisterio de Ciencia e Innovación (MICIN). EspañaEuropean Commission (EC)Instituto de Salud Carlos IIIJunta de AndalucíaUniversidad de Sevilla2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/172458https://doi.org/10.1080/15476286.2025.2483484reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésRNA Biology, 22 (1), 1-11.CA21154 TRANSLACOREPID2022-136564NB-I00FORT23/00008PI16/00090PI19/01266PI-0216–2000CB16/12/00480US-1380874https://doi.org/10.1080/15476286.2025.2483484info:eu-repo/semantics/openAccessoai:idus.us.es:11441/1724582026-06-17T12:51:07Z |
| dc.title.none.fl_str_mv |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| title |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| spellingShingle |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells Contreras Bernal, Laura Hepatocellular carcinoma m6A methylation Polysome profiling Sorafenib Translation |
| title_short |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| title_full |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| title_fullStr |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| title_full_unstemmed |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| title_sort |
Sorafenib-associated translation reprogramming in hepatocellular carcinoma cells |
| dc.creator.none.fl_str_mv |
Contreras Bernal, Laura Rodríguez Gil, Alfonso Muntané Relat, Jordi Cruz Díaz, Jesús de la |
| author |
Contreras Bernal, Laura |
| author_facet |
Contreras Bernal, Laura Rodríguez Gil, Alfonso Muntané Relat, Jordi Cruz Díaz, Jesús de la |
| author_role |
author |
| author2 |
Rodríguez Gil, Alfonso Muntané Relat, Jordi Cruz Díaz, Jesús de la |
| author2_role |
author author author |
| dc.contributor.none.fl_str_mv |
Fisiología Médica y Biofísica Genética European Cooperation in Science and Technology Ministerio de Ciencia e Innovación (MICIN). España European Commission (EC) Instituto de Salud Carlos III Junta de Andalucía Universidad de Sevilla |
| dc.subject.none.fl_str_mv |
Hepatocellular carcinoma m6A methylation Polysome profiling Sorafenib Translation |
| topic |
Hepatocellular carcinoma m6A methylation Polysome profiling Sorafenib Translation |
| description |
Sorafenib (Sfb) is a multikinase inhibitor regularly used for the management of patients with advanced hepatocellular carcinoma (HCC) that has been shown to increase very modestly life expectancy. We have shown that Sfb inhibits protein synthesis at the level of initiation in cancer cells. However, the global snapshot of mRNA translation following Sorafenib-treatment has not been explored so far. In this study, we performed a genome-wide polysome profiling analysis in Sfb-treated HCC cells and demonstrated that, despite global translation repression, a set of different genes remain efficiently translated or are even translationally induced. We reveal that, in response to Sfb inhibition, translation is tuned, which strongly correlates with the presence of established mRNA cis-acting elements and the corresponding protein factors that recognize them, including DAP5 and ARE-binding proteins. At the level of biological processes, Sfb leads to the translational down-regulation of key cellular activities, such as those related to the mitochondrial metabolism and the collagen synthesis, and the translational up-regulation of pathways associated with the adaptation and survival of cells in response to the Sfb-induced stress. Our findings indicate that Sfb induces an adaptive reprogramming of translation and provides valuable information that can facilitate the analysis of other drugs for the development of novel combined treatment strategies based on Sfb therapy. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/11441/172458 https://doi.org/10.1080/15476286.2025.2483484 |
| url |
https://hdl.handle.net/11441/172458 https://doi.org/10.1080/15476286.2025.2483484 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
RNA Biology, 22 (1), 1-11. CA21154 TRANSLACORE PID2022-136564NB-I00 FORT23/00008 PI16/00090 PI19/01266 PI-0216–2000 CB16/12/00480 US-1380874 https://doi.org/10.1080/15476286.2025.2483484 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Taylor and Francis Ltd. |
| publisher.none.fl_str_mv |
Taylor and Francis Ltd. |
| dc.source.none.fl_str_mv |
reponame:idUS. Depósito de Investigación de la Universidad de Sevilla instname:Universidad de Sevilla (US) |
| instname_str |
Universidad de Sevilla (US) |
| reponame_str |
idUS. Depósito de Investigación de la Universidad de Sevilla |
| collection |
idUS. Depósito de Investigación de la Universidad de Sevilla |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869422585520848896 |
| score |
15,81155 |